Stroke symptoms often differ between men and women, making female strokes harder to recognize. Women may experience subtle ...
NEI Highlights Groundbreaking Presentation on Accommodations: "Accommodation Planning for Real Life"A New Standard for Actionable, Neurodivergent-Affirming Support ST. PETERSBURG, FL / ACCESS Newswire ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Bayer stock may offer upside despite litigation and debt risks. Learn how recent developments could unlock value for BAYZF ...
TAMPA, FLORIDA / ACCESS Newswire / December 9, 2025 / The Neurodivergent Empowerment Institute (NEI), Florida's newest destination for neurodivergent care and wellness innovation, is leading a ...
Norwich Research Park’s third annual Innovation Hothouse competition announced its winners in November, as part of the latest ...
Bayer’s menopause drug, Lynkuet, received a recommendation for approval from the European Medicines Agency (EMA), moving it ...
HeraMED Limited ( OTCPK:HMDLF) Discusses TGA Approval, Philips Partnership, and Lee Health Pilot Launch December 3, 2025 6:30 PM EST ...
Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...
If you’re in menopause, you may be more likely to get new health problems because of changes that happen when your body stops producing estrogen. One of these health problems can be nonalcoholic fatty ...
The latest episode of the Nursing in Practice Podcast hosts a conversation exploring the planned introduction of menopause ...
Menin inhibitors target the interaction between menin and the KMT2A complex, offering a breakthrough in treating acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results